A French study has provided evidence that extended use of beta-blockers does not provide any survival benefit for patients after acute myocardial infarction. The findings validate what most Australian clinicians are already doing – discontinuing the drugs after about 12 months for MI patients without heart failure or LV dysfunction. Associate Professor John Amerena, director ...
Ischaemic heart disease
Evidence catches up with clinical practice on beta-blockers
27 Sep 2016